Publication: 260

Publication: 260

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Breast Cancer Res Treat vol 113 (3) 479-490

Year:: 2009
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Long-Term-Followup
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:: U10 CA047577, U10 CA032291, U10 CA035279, U10 CA045808, U10 CA031946, CA77651, U10 CA033601, CA60138, U10 CA035421, U10 CA077440, U10 CA041287, U10 CA077651, U10 CA003927

Corr. Author:
Authors:: G. G. Kimmick C. Cirrincione D. B. Duggan K. Bhalla N. Robert D. Berry L. Norton S. Lemke I. C. Henderson C. Hudis E. Winer

Networks:

Study: Alliance-8944
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:

Keywords:: Breast cancer, Chemotherapy, Locally advanced, Long-term follow-up, Neoadjuvant, Stage III